Progress in reproductive medicine is shaped not only in clinics and laboratories, but also through thoughtful discussion between specialists who bring different experience to the table.
Dr. S. Vyjayanthi, Director & Consultant Fertility Specialist at MotherToBe Fertility Centre & Academy, will take the international stage as Moderator of the session on “Ovulatory Disorders” at The ReproMed Series 2026 – International Webinars in Reproductive Medicine & Surgery.
The session, featuring the focused discussion “Point of View: Managing Fertility in PMOS,” will be held on Sunday, 20 September 2026, from 6:00 PM to 8:00 PM IST.
The ReproMed Series 2026 is organised by AICC RCOG in association with RCOG, RILG and IRCs of South Asia, bringing reproductive medicine professionals together for specialist-led academic exchange.
For Dr. Vyjayanthi, the webinar sits naturally within her clinical and professional interests, particularly fertility management, ovulatory disorders and reproductive medicine.
Dr. S. Vyjayanthi as Moderator: Guiding the Discussion on Ovulatory Disorders
At this international webinar, Dr. S. Vyjayanthi will moderate the session on “Ovulatory Disorders,” including the discussion “Managing Fertility in PMOS.” Her role goes beyond participating in the meeting. As Moderator, she will help guide the expert conversation, connect different clinical viewpoints and facilitate a focused discussion around fertility management and ovulatory dysfunction.
Specialists from India, the United Kingdom and Pakistan will take part, giving the session a genuinely cross-border mix of clinical perspectives.
Joining the discussion are Dr. Himanshu Borase (UK), Dr. Salma Zubair (Pakistan), Dr. Ranjit Joshi and Dr. Mandira Dasgupta, with the programme also addressing the management of ovulatory dysfunction in other endocrinopathies.
The ReproMed Series 2026: Connecting Expertise Across Borders
The ReproMed Series 2026 – International Webinars in Reproductive Medicine & Surgery provides a platform for focused professional conversations in reproductive healthcare. Organised by AICC RCOG in association with RCOG, RILG and IRCs of South Asia, the series connects specialists across regions and encourages the exchange of clinical experience, contemporary perspectives and approaches to reproductive medicine.
The upcoming discussion on “Managing Fertility in PMOS”, moderated by Dr. S. Vyjayanthi, reflects this collaborative approach. Rather than viewing fertility management in isolation, the discussion brings ovulatory disorders into the wider context of reproductive health and associated endocrine factors.
Why Metabolic Health Is Central to PMOS
The shift from PCOS (Polycystic Ovary Syndrome) to PMOS (Polyendocrine Metabolic Ovarian Syndrome) reflects a broader understanding of the condition. The new name moves attention away from the idea that the syndrome is defined mainly by “polycystic” ovaries and instead recognises its interconnected endocrine, metabolic and ovarian features. In 2026, a global consensus process involving patients, clinicians and professional organisations established PMOS as the new terminology, with “polyendocrine,” “metabolic” and “ovarian” chosen to better represent the multisystem nature of the condition.
Metabolic health is therefore not a side issue in PMOS; it is part of what the new name is intended to make more visible. PMOS can involve metabolic features such as insulin resistance and changes in glucose regulation, alongside hormonal and reproductive manifestations. This wider framing encourages clinicians and patients to consider health beyond menstrual cycles, ovulation or ovarian appearance alone, including appropriate assessment of metabolic risk as part of long-term care.
This reframing is particularly relevant when discussing fertility. Ovulatory dysfunction may affect the chance of conception for some women with PMOS, but fertility care should sit within a broader, individualised assessment of reproductive and metabolic health. Importantly, the 2026 terminology update changes the name rather than the underlying evidence-based recommendations: the updated international guideline states that its recommendations and content remain unchanged during the transition to PMOS terminology.
Why the Conversation Around Ovulatory Disorders Matters
Ovulation is central to natural conception, so disrupted ovulatory function can be an important part of a fertility assessment. Even so, it is rarely the only factor that needs attention.
A specialist may need to consider menstrual and ovulatory patterns alongside reproductive history, age, ovarian reserve, hormonal factors and other clinical findings before determining appropriate next steps.
For patients interested in understanding fertility concerns related to polycystic ovary syndrome, MotherToBe provides detailed information on PCOS treatment and fertility care in Hyderabad through its dedicated PCOS resource.
Specialist Expertise Behind the Moderation
Dr. S. Vyjayanthi brings extensive specialist training in reproductive medicine, reproductive surgery and embryology to her role at The ReproMed Series 2026. Her qualifications include MD, DGO, DNB, MRCOG, MSc (Embryology, UK) and CCT (UK), and she is a Subspecialist in Reproductive Medicine & Surgery (RCOG, UK).
Her international training includes a Clinical Fellowship in Reproductive Medicine at Leeds Reproductive Medicine Unit, UK, an MSc in Embryology from the University of Leeds, UK, and a Subspecialty Fellowship in Reproductive Medicine & Surgery at St Bartholomew’s Hospital, London, UK.
Her professional involvement includes serving as President, Telangana Chapter RCOG; Managing Committee Member, PCOS Society of India; and Managing Committee Member, Fertility Preservation Society of India.
Readers can learn more about Dr. S. Vyjayanthi’s reproductive medicine expertise and professional background on her dedicated MotherToBe profile.
From Ovulatory Disorders to Individualised Fertility Care
One of the most important principles in reproductive medicine is that fertility care needs to reflect the individual. For some patients, the concern may involve ovulation. For others, assessment may involve ovarian reserve, uterine or tubal factors, male fertility parameters, previous pregnancy history or a combination of factors.
Depending on clinical findings, patients may be advised to consider approaches ranging from monitoring and appropriate medical management to IUI treatment as one possible assisted-reproduction pathway.
Where clinically appropriate, patients can also learn more about IVF treatment in Hyderabad.
For people considering future reproductive potential, MotherToBe also provides information on fertility preservation in Hyderabad.
Patients specifically exploring oocyte preservation can read about egg freezing in Hyderabad.
An International Exchange in Reproductive Medicine
The strength of a professional meeting often lies in the perspectives it brings together. With specialists participating from India, the UK and Pakistan, this ReproMed Series 2026 session creates an opportunity for cross-border academic exchange around fertility management and ovulatory dysfunction.
As Moderator, Dr. S. Vyjayanthi will help shape that exchange by keeping the discussion purposeful, linking different viewpoints and bringing the conversation back to the session’s central clinical questions.
Event at a Glance
- Conference: The ReproMed Series 2026
- Programme: International Webinars in Reproductive Medicine & Surgery
- Session: Ovulatory Disorders
- Discussion: Point of View: Managing Fertility in PMOS
- Moderator: Dr. S. Vyjayanthi
- Date: Sunday, 20 September 2026
- Time: 6:00 PM – 8:00 PM IST
- Format: International Webinar
- Organised by: AICC RCOG in association with RCOG, RILG & IRCs of South Asia
Bringing Expertise, Perspectives and Purpose Together
The ReproMed Series 2026 offers something practical beyond a single lecture: a space where specialists from different settings can compare experience, question assumptions and share clinical perspectives.
For the session on Ovulatory Disorders and “Managing Fertility in PMOS,” Dr. S. Vyjayanthi’s role as Moderator places her at the heart of this international conversation. Backed by her specialist training in reproductive medicine and surgery, embryology experience and professional association with RCOG, she will guide a discussion designed to bring different perspectives together around an important area of fertility care.
A conversation beyond borders. A meeting of clinical perspectives. A shared commitment to advancing reproductive medicine.
To discuss individual fertility concerns with the MotherToBe clinical team, book a fertility consultation.
